Alkermes plc (Nasdaq: ALKS) recently announced the presentation of new research from its psychiatry portfolio at the 2021 Congress of the Schizophrenia International Research Society (SIRS), taking place virtually April 17-21, 2021.
We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting.
Bacteria growth in flooring of hospitals, grocery stores, warehouses, etc. is extremely dangerous for human health. A more permeable surface is a result of a porous material that is more susceptible to this harmful bacterial growth.
Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW™ COVID-19 Ag Self Test for detection of COVID-19 infection.